Tissue culture is the in-vitro procedure for culturing tissues aseptically using growth medium. Insect cell culture is a special media used for production of vaccines, virus like particles and recombinant proteins.
Thomas D.C Grace, in 1962 established the first insect cell culture medium namely Emperor Gum Moth Antherea Eucalipty. There are about more than 500 from 75 different species.
Lepidopteram, Diptern, Orthopteran are some species of insects used for insect cell lines. Insect cell line usually take 18-72 hours doubling time.
Insect cell lines has various advantages in vaccine production as it is capable of post translational modifications, high protein expression yield during vaccine production against virus.
To remain ahead of your competitors, request for a sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-11503
Insect cell lines Market: Drivers and Restraints
Rise in prevalence of chronic disease like cancer is a prime factor driving the growth of insect cell lines market. Also, rising awareness regarding advanced therapies using genetic engineering may upsurge the demand for insect cell lines market.
The American Cancer Society estimates that in 2020, about 21,750 new cases of ovarian cancer will be diagnosed and 13,940 women will die of ovarian cancer in the United States.
This has led the high focus of pharmaceutical industry to provide utter quality of vaccines for viral related cancers cancer may also responsible for the rapid progress of insect cell lines market. Additionally, the availability of favorable reimbursement scenario in developed economies will also propel the growth of insect cell lines market.
On the other hand, prohibitive cost of insect cell lines and lack of funding may deter the growth of insect cell lines market in under developing economies.
Insect cell lines Market: Overview
Among product type, High Five insect cell lines captures the highest revenue share as the cell line produce higher levels of recombinant proteins used in medicine. Also, High Five insect lines survive in serum free media that helps to make it contamination free.
These cell lies can be produced using E. coli due to its high reproducibility property. Among all application of biopharmaceutical industries will hold the highest share as the increased funding for research and development for vaccine production.
Among all end user, pharmaceutical industry will hold the largest share segment in insect cell lines market and is anticipated to grow at a significant rate over the forecast period.
For in-depth insights, Download a PDF Brochure @
https://www.futuremarketinsights.com/reports/brochure/rep-gb-11503
Insect cell lines Market: Regional Overview
North America will show the high revenue for the insect cell lines market, as the prevalence of chronic disease is more in the region and increased funding for vaccine development to pharmaceutical industry.
After North America, the Europe region will show the robust growth for the insect cell lines market in the near future, due to availability of better R&D infrastructure European countries.
Latin America region will show the significant demand for the insect cell lines, due to the regional government initiative towards the health in countries like Brazil and Mexico.
In Asian countries like China and India, may show the additional demand for the insect cell lines as the people are being aware about treatment using advanced therapies using genetic engineering.
The Middle East and Africa are expected to be least lucrative region for insect cell lines market due to lack of awareness about the women health.
Insect cell lines Market: Key Players
Examples of some of the market participants in Insect cell lines market identified across the value chain include Corning (Cellgro), Thermo Fisher, GE Healthcare Lonza, Hi-Media, Merck Millipore, CellGenix, Atlanta Biologicals, PromoCell and others.
Product launches is the main strategy followed by the manufacturers for insect cell lines market. On March 2020, Lonza has launched a new insect cell line medium to increase the production of Adeno Associated Virus (AAV) in Spodoptera Fuigiperda (Sf9) insect cells lines.
The research report on insect cell lines market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.
The research report on Insect cell lines market provides analysis and information according to market segments such as geographies, application, and industry.
Report on Insect cell lines market includes regional analysis
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Europe (Germany, Italy, France, U.K, Spain, Russia)
- East Asia (China, Japan, South Korea)
- South Asia (India, ASEAN)
- Oceania (Australia, New Zealand)
- Middle East and Africa (GCC Countries, South Africa, Northern Africa)
The report on insect cell lines market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Request for Report Ask A Question @
https://www.futuremarketinsights.com/ask-question/rep-gb-11503
Insect cell lines Market: Segmentation
The global insect cell lines market is classified on the basis of product type, application, and end user
Based on product type, insect cell lines market is segmented into the following:
- Sf9
- Sf21
- High Five
Based on application, insect cell lines market is segmented into the following:
- Biopharmaceutical Manufacturing
- Tissue Culture & Engineering
- Gene Therapy
- Cytogenetic
Based on end user, insect cell lines market is segmented into the following:
- Pharmaceutical industry
- Research laboratories
- Pathology labs
- Others
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs